Heberprot-P

The Cuban medicine Heberprot-P, intended for the treatment of patients with diabetic foot ulcers in advanced states and at high risk of amputation, was promoted within the framework of the Exhibition and International Forum of Medical Innovations of Azerbaijan held in Baku.

At the meeting of the Island's ambassador, Alfredo Nieves Portuondo, with executives of the Russian-Azerbaijani company, R-Pharm LLC, contacts began to explore future collaborations with Cuban companies.

Ulaanbaatar, Mongolia. March 20, 2019. On the morning of Tuesday, March 19, the training program of the Mongolian medical specialists of The First Hospital of Ulaanbaatar for the use and application of the Cuban biotechnological product Heberprot-P began. As a result of the MoU signed on February 23, between this health institution, the Center for Genetic Engineering and Biotechnology (CIGB) of Cuba and the Mongolian pharmaceutical company Mongolian Import and Export Concern, the training program will feature master classes, conferences and specialized consultations that will be given by Dr. Yanisbel Ortiz Peña, 1st Degree Specialist in Angiology and Vascular Surgery of the CIGB.

Ulan Bator, September 25, 2018. - As part of her work visit to Mongolia, Dr. Yanisbel Ortiz Peña, specialist of the Center for Genetic Engineering and Biotechnology, participated in a scientific event organized by InterCharm Clinic on techniques, procedures and products. new and updated in dermatological and cosmetic treatments, where she made a presentation about the Cuban product Heberprot-P.